Oculus VR headset for depressive disorder, treatment-resistant

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Jan 2025: Trial registered, NCT06781697
  2. 3 May 2026: Trial started, NCT06781697

The trials

NCT06781697: InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression

State
Under way
Phase
Phase 3
People
31 planned
Started
3 May 2026
Primary completion
Dec 2027
Arms
VR-Ketamine (VR-K)
Results
None posted
  1. 17 Jan 2025: Trial registered
  2. 3 May 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.